Cargando…

Highthroughtput analysis of behavior for drug discovery

Drug testing with traditional behavioral assays constitutes a major bottleneck in the development of novel therapies. PsychoGenics developed three comprehensive highthroughtput systems, SmartCube(®), NeuroCube(®) and PhenoCube(®) systems, to increase the efficiency of the drug screening and phenotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexandrov, Vadim, Brunner, Dani, Hanania, Taleen, Leahy, Emer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552324/
https://www.ncbi.nlm.nih.gov/pubmed/25592319
http://dx.doi.org/10.1016/j.ejphar.2014.11.047
_version_ 1782387712036175872
author Alexandrov, Vadim
Brunner, Dani
Hanania, Taleen
Leahy, Emer
author_facet Alexandrov, Vadim
Brunner, Dani
Hanania, Taleen
Leahy, Emer
author_sort Alexandrov, Vadim
collection PubMed
description Drug testing with traditional behavioral assays constitutes a major bottleneck in the development of novel therapies. PsychoGenics developed three comprehensive highthroughtput systems, SmartCube(®), NeuroCube(®) and PhenoCube(®) systems, to increase the efficiency of the drug screening and phenotyping in rodents. These three systems capture different domains of behavior, namely, cognitive, motor, circadian, social, anxiety-like, gait and others, using custom-built computer vision software and machine learning algorithms for analysis. This review exemplifies the use of the three systems and explains how they can advance drug screening with their applications to phenotyping of disease models, drug screening, selection of lead candidates, behavior-driven lead optimization, and drug repurposing.
format Online
Article
Text
id pubmed-4552324
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-45523242016-03-05 Highthroughtput analysis of behavior for drug discovery Alexandrov, Vadim Brunner, Dani Hanania, Taleen Leahy, Emer Eur J Pharmacol Article Drug testing with traditional behavioral assays constitutes a major bottleneck in the development of novel therapies. PsychoGenics developed three comprehensive highthroughtput systems, SmartCube(®), NeuroCube(®) and PhenoCube(®) systems, to increase the efficiency of the drug screening and phenotyping in rodents. These three systems capture different domains of behavior, namely, cognitive, motor, circadian, social, anxiety-like, gait and others, using custom-built computer vision software and machine learning algorithms for analysis. This review exemplifies the use of the three systems and explains how they can advance drug screening with their applications to phenotyping of disease models, drug screening, selection of lead candidates, behavior-driven lead optimization, and drug repurposing. 2015-01-12 2015-03-05 /pmc/articles/PMC4552324/ /pubmed/25592319 http://dx.doi.org/10.1016/j.ejphar.2014.11.047 Text en http://creativecommons.org/licenses/by/4.0/ This manuscript version is made available under the CC BY-NC-ND 4.0 license.
spellingShingle Article
Alexandrov, Vadim
Brunner, Dani
Hanania, Taleen
Leahy, Emer
Highthroughtput analysis of behavior for drug discovery
title Highthroughtput analysis of behavior for drug discovery
title_full Highthroughtput analysis of behavior for drug discovery
title_fullStr Highthroughtput analysis of behavior for drug discovery
title_full_unstemmed Highthroughtput analysis of behavior for drug discovery
title_short Highthroughtput analysis of behavior for drug discovery
title_sort highthroughtput analysis of behavior for drug discovery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552324/
https://www.ncbi.nlm.nih.gov/pubmed/25592319
http://dx.doi.org/10.1016/j.ejphar.2014.11.047
work_keys_str_mv AT alexandrovvadim highthroughtputanalysisofbehaviorfordrugdiscovery
AT brunnerdani highthroughtputanalysisofbehaviorfordrugdiscovery
AT hananiataleen highthroughtputanalysisofbehaviorfordrugdiscovery
AT leahyemer highthroughtputanalysisofbehaviorfordrugdiscovery